News
Devyser’s breakthrough NGS product for hereditary breast and ovarian cancer testing now approved for diagnostic use in the EU
Stockholm, 22 July 2020 —Swedish genetic test developer Devyser’s product for hereditary breast and ovarian cancer (HBOC) is now CE labelled and approved for diagnostic
Discover Devyser CFTR 68
https://vimeo.com/434385139/77bd5832b6 Discover Devyser CFTR 68, our latest kit for the analysis of the CFTR gene, capable of detecting up to 68 mutations most commonly associated
Join our Q&A Poster viewings at the ESHG 2020 Virtual Conference!
The Q&A Poster viewing sessions at ESHG 2020 Virtual Conference will highlight two of our products: Devyser RHD, a non-invasive risk screening kit for RhD-negative
World Haemochromatosis Week 2020
From June 1st to June 7th 2020 is World Haemochromatosis Week. Hemochromatosis is characterised by an excess of iron in blood. Causes for the disease
Devyser gears up for global sales of genetic tests — recruits Torbjörn Andersson as Chief Commercial Officer
Stockholm, 26 may 2020 — Devyser welcomes Torbjörn Andersson as Chief Commercial Officer in charge of global sales and marketing of Devyser’s genetic tests. Torbjörn has
World Ovarian Cancer Day 2020
The 8th of May is World Ovarian Cancer Day. Bringing awareness about this illness is especially important these days, as COVID-19 is affecting ovarian cancer
Event reorganisations for EFI and ESHG 2020
The current circumstances caused two of our next events to be reorganised. The EFI 2020 conference, originally planned for the end of this week, has
What Devyser is doing through the COVID-19 crisis
First and foremost, we are ensuring the well-being of our employees and the continuity of our products and services to serve our customers. We have
EFI 2020 postponed
Unfortunately, the EFI 2020 conference has been postponed due to the current COVID-19 pandemic concerns. Another date will be communicated to us soon! Meanwhile, let
Recent Posts
- Devyser’s breakthrough NGS product for hereditary breast and ovarian cancer testing now approved for diagnostic use in the EU
- Discover Devyser CFTR 68
- Join our Q&A Poster viewings at the ESHG 2020 Virtual Conference!
- World Haemochromatosis Week 2020
- Devyser gears up for global sales of genetic tests — recruits Torbjörn Andersson as Chief Commercial Officer